Depression Conceptualization and Treatment
59,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Gebundenes Buch

Depression, a highly common clinical disorder, is an important and clinically relevant topic for both clinical researchers and practitioners to address, because of its prevalence, impact on the individual and society, association with other mental and physical health problems and the social contexts in which it develops. Depression ranks in Germany and central Europe as the third among the leading mental disorders and world-wide is a leading cause of disability. It is estimated that 8.3 % of the German population is depressed within a year (11.2 % women, 5.5 % men). These statistics mean that…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Depression, a highly common clinical disorder, is an important and clinically relevant topic for both clinical researchers and practitioners to address, because of its prevalence, impact on the individual and society, association with other mental and physical health problems and the social contexts in which it develops. Depression ranks in Germany and central Europe as the third among the leading mental disorders and world-wide is a leading cause of disability. It is estimated that 8.3 % of the German population is depressed within a year (11.2 % women, 5.5 % men). These statistics mean that 4 million people per year are depressed in Germany alone (one year prevalence). According to the WHO, over 300 million people world-wide experience depression and in the USA the financial burden of this disorder, due to disability and work absenteeism, reaches Depression is also becoming more frequent over time and has a high risk of recidivism -particularly since its most common form, Major Depressive Disorder (DSM-5; ICD10) tends to occur in episodes. For example, 20% to 40% of people become depressed again within two years after their first depressive episode, meaning that a major aim of any therapeutic intervention should be to prevent future relapses. Depression also shows very high comorbidities with other mental and physical health conditions. Its overlap with anxiety pathology is so high that clinicians are concerned with whether the two disorder categories are indeed distinct or if they show substantial etiological overlap. Depression is also associated with heart disease and even cancer, making it a risk factor for mortality and morbidity that needs to be identified early and addressed effectively. In addition to Major Depressive Disorder, the often severe Bipolar Disorder, and the chronic form of Depression referred to as dysthymia are additional mood disorders that among them require careful differential diagnosis. They also lead to questions regarding their common or distinct etiological mechanisms.

In order to gain a better understanding of Depression as a clinical disorder, one needs to look at it as a multifaceted phenomenon. Depression is a neurobehavioral condition, and one has to be up to date and have solid understanding of its biological substrate, at a genetic, neuronal, hormonal and pharmacological level. Depression is also a socio-demographic phenomenon, and one needs to examine its epidemiology, that might contain significant cues towards its clearer understanding. It is more prevalent, for example, in certain regions, climates, age groups and genders (much more prevalent in women, with age of appearance in young adulthood but also presents as a significant problem for youth and the elderly), is associated with stereotypes and stigma and can be the aftermath of crises, trauma and loss.

The etiology of Depression remains under scrutiny, though recently much more knowledge is emerging from contemporaryneuroimaging, genotyping and data science methods. Different neural and behavioral systems may be involved contributing to the significant heterogeneity within the disorder. Social roles, stressors, attachment patterns, family support and social networks, and individual (e.g. gender linked) vulnerabilities may contribute significantly towards increasing risk for developing depression. Different therapeutic approaches, like those stemming from the psychoanalytic/psychodynamic perspectives and those stemming from the cognitive/behavioral (2nd and 3rd wave) tradition focus on the components of etiology considered most dominant. As science progresses with clearer evidence regarding the important etiological factors and their interactions, these different perspectives, each with its own contribution, may need to take new developments into consideration, adapt and even begin to converge.

These different aspects of the topic of Depression, which ar
Autorenporträt
Christos ¿Charis has been working for many years as a specialist in psychiatry / psychotherapy and specialist in psychosomatics and psychotherapy. Since October 2006 he has been working as a psychodynamic psychotherapist in his own practice. At the same time he has been working since 2006 as a psychiatric and psychotherapeutical consultant one day per week at the psychiatric hospital (part-time): Vitos Klinik Bamberger Hof, Frankfurt am Main, Germany.  The focus of his psychodynamic work is depression, anxiety disorders and psychosomatic disorders. Together with Professor Georgia Panayiotou he edited the book Somatoform and other Psychosomatic Disorders, 2017 Springer Verlag. He is a member of the psychosomatic association: Berufsverband deutscher Psychosomatik und ärztlicher Psychotherapie, Berlin, Germany. Georgia Panayiotou, Ph.D. is Professor of Clinical Psychology at the University of Cyprus. She holds a BA degree in Psychology and Sociology from New College of Florida, and a Masters and Ph.D. in Clinical Psychology from Purdue University, Indiana. She completed her Doctoral Clinical Internship at McLean Hospital/Harvard Medical School and was assistant professor at Mississippi State University before her return to Cyprus. Her primary research interests are in the domain of emotions and emotional processes in psychopathology and their interaction with cognitive processes. She studies primarily anxiety disorders, alexithymia, antisocial disorders and addictions, with the use of both self-report and psychophysiological methods. She is interested in how people experience, process and regulate their emotions and how this is related to mental health and wellbeing. In addition to examining basic processes involved in the etiology and maintenance of these disorders, she has conducted, with her students, several RCTs on preventive and therapeutic interventions for young people, which focus on various aspects of emotiondysregulation. She has co-ordinated or was co-PI on multiple nationallyand internationally funded projects (including Marie-Curie ETN, Erasmus Plus etc.)and is a founding member of the Center for Applied Neurosciences at the University of Cyprus. She is Chair of the Board of the University Mental Health Center and the Cyprus Cancer Research Institute and has been appointed by the Government on several national boards. She sits on editorial boards of several journals. In addition to her scholarly work, she is a licensed clinical psychologist andserved several terms as vice-chair of the Cyprus Psychologists Association and Cyprus Professional Psychology Licensing Board. She has supervised9 completed and 4 ongoing PhDs and numerousMA theses.